Results 31 to 40 of about 349,588 (308)

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis

Zhongguo shuxue zazhi
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness.
ZHU Jianling, CHENG Tingting, MA Chunya, FU Lihui, SHI Hongmei, YU Yang   +5 more
doaj   +1 more source

Study on relationship between platelet transfusion efficacy and KIR-HLA receptor-ligand compatibility

Zhongguo shuxue zazhi, 2023
Objective To study the correlation between platelet transfusion efficacy and KIR receptor-HLA ligand. Methods Thirty-three leukemia patients with positive HLA antibody were tested for cross-matching with donor platelets.
Yu HAN, Fan YANG, Lixin JIAO, Lingling LIU, Jianghong YU, Tingting NIE, Xin LIU, Rixin BAI, Xu YANG, Ying CHEN, Yanfei LI, Kaiye LI, Xiaotang YU   +12 more
doaj   +1 more source

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation

Zhongguo shuxue zazhi
[Objective] To evaluate the platelet transfusion requirements in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation (ASCT), and to identify risk factors for increased transfusion needs and ...
FU Xiaoyan, ZHEN Zida, QIU Lijuan, ZHANG Huimin, WANG Mengjian, ZHANG Shuaihang, MA Shuxuan   +6 more
doaj   +1 more source

Dose- and time-related platelet response with apheresis platelet concentrates and pooled platelets

Bangabandhu Sheikh Mujib Medical University Journal, 2017
This study was carried out to compare the post-transfusion platelet increment between the apheresis platelet concentrate (n=74) and pooled platelets (n=54).
Mohammad Mizanur Rahman, Lutfunnahar Khan, Debashish Saha   +2 more
doaj   +1 more source

Prophylactic platelet transfusions [PDF]

Vox Sanguinis, 2012
info:eu-repo/semantics ...
Pietersz, R N I, Reesink, Henk, Panzer, S, Gilbertson, M P, Borosak, M E, Wood, E M, Leitner, G C, Rabitsch, W, Ay, C, Lambermont, Micheline, Deneys, Véronique, Sondag, D, Compernolle, V, Legrand, Danielle, François, A, Tardivel, R, Garban, F, Sawant, R B, Rebulla, P, Handa, M, Ohto, H, Kerkhoffs, J-L H, Brand, A, Zhiburt, E, Cid, José Angel, Escolar, G, Lozano, Manolo, Puig, Luisa, Knutson, F, Hallböök, H, Lubenow, N, Estcourt, L, Stanworth, S, Murphy, M F, Williams, L, Mraz, D L, Ross, R L, Snyder, Evan Y.   +37 more
openaire   +5 more sources

Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis

Systematic Reviews
Background Critical bleeding events in adults and children with ITP are medical emergencies; however, evidence-based treatment protocols are lacking. Due to the severe thrombocytopenia, (typically platelet count less than 20 × 109/L), a critical bleed ...
Emily Sirotich, Hasmik Nazaryan, Saifur Rahman Chowdhury, Gordon Guyatt, Arnav Agarwal, Russell Leong, Aaron Wen, Emily Xu, Bonnie Liu, Sushmitha Pallapothu, Preksha Rathod, Henry Y. Kwon, Jared Dookie, Amirmohammad Shafiee, Jay Charness, Jennifer DiRaimo, Dale Paynter, Barbara Pruitt, Gail Strachan, Rachel Couban, Zhikang Ye, Donald M. Arnold   +21 more
doaj   +1 more source

Neonatal Thrombocytopenia and the Role of the Platelet Mass Index in Platelet Transfusion in the Neonatal Intensive Care Unit

Balkan Medical Journal, 2020
Background: Neonatal thrombocytopenia is a common hematological abnormality that occurs in 20–35% of all newborns in the neonatal intensive care unit.
Tuba Kasap, Şahin Takçı, Burcu Erdoğan Irak, Rüveyda Gümüşer, Ergün Sönmezgöz, Ali Gül, Osman Demir, Umut Safiye Şay Coşkun   +7 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China

, 2010
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive care. To improve the effectiveness of platelet transfusion therapy in PTR patients, we aimed to establish a platelet donor registry in our region ...
Xu, Xiuzhang, Ye, Xin, Fu, Yongshui, Xia, Wenjie, Santoso, Sentot, Chen, Yangkai, Deng, Jing, Luo, Guangping, Tian, Linwei, Bei, C. H.   +9 more
core   +1 more source

Evaluation of PEscore performance in predicting platelet transfusion efficacy in hematological patients

Zhongguo shuxue zazhi
[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun, WANG Lan, XIE Yihua, CHEN Ziqi, ZHAO Gang   +4 more
doaj   +1 more source